JPRN-UMIN000039040已完成未知
Pharmacological Risk Modification for Progression into Symptomatic Dementia: Complete Enumeration Study Utilizing Administrative Claims Record in Kashiwa City - Pharmacological Risk Modification for Progression into Symptomatic Dementia
Tokyo Metropolitan geriatric Medical Center and Institute of Gerontology0 个研究点目标入组 44,303 人开始时间: 2020年1月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 44,303
研究概览
简要总结
In addition to older age and female sex, use of the following medications was significantly associated with NPADM: statins (HR: 0.82; p=0.001), antihypertensives (HR: 0.80; p<0.0001), non-steroidal bronchodilators (HR: 0.728; p=0.002), antidepressants (HR: 1.79; p<0.0001), poststroke medications (HR: 1.45; p=0.002), insulin (HR: 1.34; p=0.046) and antineoplastics (HR: 1.12; p=0.035).
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 77years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. All residents in Kashiwa city who are equal to or younger than 76 years old at April 2012 2. All residents who had prescription of anti-dementia medication while between April and June 2012.
研究者
相似试验
已完成
2 期
The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET)Essential ThrombocythaemiaNCT00413634Shire24
已完成
不适用
Evaluation of a Drug Interactions Software to Limit PolypharmacyPolypharmacyElderlyInpatientDrug InteractionNCT03901820University of Buenos Aires1,053
已完成
不适用
Effect of Systematic Medication Review in Elderly Patients Admitted to an Orthopedic DepartmentElderlyNCT00738816Aarhus University Hospital108
Unknown
不适用
OPTIM-EHPAD Optimization of Drug Prescription for Each Resident Entering in Nursing Home (EHPAD).Iatrogenic EffectNCT05179642Hospices Civils de Lyon2,000
招募中
不适用
Caelyx PK.pharmacokineticscaelyxcancerNL-OMON23804Erasmus University Medical Center34